Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA PMA

Laparoscopic contraceptive tubal occlusion device

PMA Number: P920046 · 2024-12-03

Decision Date2024-12-03
PMA NumberP920046
Product CodeKNH
Device ClassClass 3
Medical SpecialtyO
Regulation Number21 CFR 8
Advisory CommitteeOB

Device Summary

Laparoscopic contraceptive tubal occlusion device is the device name listed in this FDA PMA record. The listed applicant is Femcare , Ltd.. It received FDA Premarket Approval (PMA) on 2024-12-03 under PMA number P920046. The device is classified under FDA product code KNH. It was reviewed by the OB advisory panel. This device is classified as Class III by the FDA. Class III devices subject to the most stringent regulatory controls. These devices generally require premarket approval (PMA) because they support or sustain human life, are of substantial importance in preventing impairment of human health, or present a potential unreasonable risk of illness or injury. PMA is the most stringent type of device marketing application required by the FDA. The device falls under the medical specialty of O. It is regulated under 21 CFR Part 8. Unlike 510(k) clearance, which demonstrates substantial equivalence to a predicate device, PMA requires valid scientific evidence providing reasonable assurance of safety and effectiveness. PMA is generally required for Class III devices that support or sustain human life, are of substantial importance in preventing impairment of human health, or present a potential unreasonable risk of illness or injury.

Frequently Asked Questions

What is Laparoscopic contraceptive tubal occlusion device?

Laparoscopic contraceptive tubal occlusion device is a medical device that received FDA Premarket Approval (PMA) on 2024-12-03. The listed applicant is Femcare , Ltd.. The PMA number is P920046.

When did Laparoscopic contraceptive tubal occlusion device receive FDA PMA approval?

Laparoscopic contraceptive tubal occlusion device received FDA PMA approval on 2024-12-03, under PMA number P920046.

Who is the listed applicant for Laparoscopic contraceptive tubal occlusion device?

The FDA PMA record lists Femcare , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the difference between PMA and 510(k)?

PMA (Premarket Approval) is the FDA process for evaluating Class III medical devices. Unlike 510(k) clearance, which demonstrates substantial equivalence to a predicate device, PMA requires valid scientific evidence providing reasonable assurance of safety and effectiveness. PMA is the most stringent type of device marketing application required by the FDA.

What is the FDA product code for Laparoscopic contraceptive tubal occlusion device?

The FDA product code for Laparoscopic contraceptive tubal occlusion device is KNH.

What FDA device class is Laparoscopic contraceptive tubal occlusion device?

Laparoscopic contraceptive tubal occlusion device is classified as Class III by the FDA.

Related Devices (Code: KNH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.